'Y705 stat3' diaporamas de présentation

Y705 stat3 - PowerPoint PPT Presentation


8 h

8 h

2 mM GlcN. A. 0 h. 2 h. 4 h. 8 h. 12 h. 24 h. p(Y705)Stat3. Stat3. Actin. 2 mM GlcN. Controls. B. 1 h. 0 h. 4 h. 8 h. Stat3. 1. 2. 3. 4. 5. 6. 7. 8. C.

By italia
(141 views)


View Y705 stat3 PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Y705 stat3 PowerPoint presentations. You can view or download Y705 stat3 presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.

Recherches associées pour Y705 stat3
p-STAT3 (Y705)

p-STAT3 (Y705)

A. B. C. MDA-MB-453. MCF-10A. MCF-10A. + 468 CM 24 hr. + 468 CM 6 hr. + 231 CM 0.5 hr. No Tx. No Tx. Alone. + 453. + 468. p-STAT3 (Y705). p-STAT3 (Y705). p-STAT3 (Y705). STAT3. STAT3. STAT3. Actin. GAPDH. GAPDH. D. E. F. MDA-MB-453. MCF-10A.

By arwen (130 views)

STAT3

STAT3

STAT3. Michael Patel. Overview. STAT3 is a transcription activator It homodimerizes and binds to the DNA promoter region It is associated with oncogenesis, cellular differentiation, and embryogenesis. STAT3 Signaling Pathway. Involved in signal transduction pathway

By matia (334 views)

Vehicle Stat3 siRNA

Vehicle Stat3 siRNA

A. Synthetic siRNA against STAT3. 5’-CAU CUG CCU AGA UCG GCU AdTdT-3’ 3’-dTdT GUA GAC GGA UCU AGC CGA U- 5’. Vehicle Stat3 siRNA GFP siRNA. Vehicle Stat3 siRNA GFP siRNA. Vehicle Stat3 siRNA. B. a -STAT3 a - b -actin. a -STAT3 a -MAPK. A172. U251. NHA. C.

By naasir (162 views)

STAT3 Signaling Pathway

STAT3 Signaling Pathway

STAT3 Signaling Pathway. SIGMA-ALDRICH. STAT3 Signaling Pathway

By urian (602 views)

STAT3 pSTAT3 GAPDH

STAT3 pSTAT3 GAPDH

BCL-2. BCL2. GAPDH. GAPDH. Apoptotic cells (%). Apoptotic cells (%). LN229. miR21i alone. miR21i/PAMAM. U87. ( m m ). STAT3 pSTAT3 GAPDH. STAT3 pSTAT3 GAPDH. PTEN. 时序控制对替莫唑胺和反义 miR-21 联合作用的研究. 钱小敏 1 任玉 3 史振东 2 柳朝永 1 吉雅茹 1 原续波 1* 康春生 2*. 天津大学材料科学与工程学院,天津 300072

By darin (198 views)

STAT3 and the Immune System

STAT3 and the Immune System

STAT3 and the Immune System. Maureen Sherry Lynes February 29, 2012. Overview. STAT family; STAT3 signaling and structure Role of STAT3 revealed by tissue specific knockouts STAT3 and the anti-tumor immune response Therapeutic approaches for targeting STAT3 Paper discussion.

By stockman (0 views)

N-Term. STAT3 (S21320/ 610190)

N-Term. STAT3 (S21320/ 610190)

- UV + UV. C. A. - D - D. AG490 MG. ( m M). 132. - D 1 10 100 50 -. 97.1 kDa -. 102 -. C-Term. C-Term. C-Term. C-Term. C-Term. 67.3 kDa -. 71 -. STAT3 a. STAT3 a. STAT3 a. STAT3 a. STAT3 a. 46 -. Cytopl. 43.9 kDa -. (sc-482). (sc-482). (sc-482).

By diem (168 views)

Read genomic coordinates of STAT3 binding

Read genomic coordinates of STAT3 binding

Cross linking protein/DNA. Cells. Shear DNA strands by sonification. Immunopeecipitation with bead attached anti-STAT3 antibodies . Reverse crosslinks. Sequence. Align to genome . Read genomic coordinates of STAT3 binding. Read miR promoter genomic coordinates. Figure S1.

By kalei (120 views)

Read genomic coordinates of STAT3 binding

Read genomic coordinates of STAT3 binding

Cross linking protein/DNA. Cells. Shear DNA strands by sonification. Immunopeecipitation with bead attached anti-STAT3 antibodies. Reverse crosslinks. Sequence. Align to genome. Read genomic coordinates of STAT3 binding. Read miR promoter genomic coordinates. Figure S1.

By oliver-nichols (89 views)

SHP-1 reverses trastuzumab resistance and migration in HER2-positive breast cancer cells through the stat3/p-stat3 pathw

SHP-1 reverses trastuzumab resistance and migration in HER2-positive breast cancer cells through the stat3/p-stat3 pathw

Decreased expression of Src homology region 2 domain containing protein tyrosine phosphatase 1 (SHP-1) was found in human breast cancer cell lines and primary breast cancers. As a candidate tumor suppressor gene, the role of SHP-1 in HER-2-positive breast cancer remains to be elucidated. The aim of the present study was to investigate the effects of upregulated SHP-1 expression in reversing trastuzumab resistance and migration by HER-2-positive breast cancer cells, potentially providing a new target to trastuzumab resistance in anti-HER2 therapy.

By alliedacademies (1 views)